Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Regulatory Status AOD-9604 is not FDA-approved for any medical use and is listed by the FDA as a bulk drug substance that may present safety risks. Clinical development was halted after Phase IIb trials failed to meet efficacy endpoints. Summary AOD-9604 is a synthetic analog of the HGH 177191 fragment developed for fat-metabolism research
Bremelanotide can cause significant nausea (reported in up to 40% of users in clinical trials), increased blood pressure, and flushing
50 years of research, 200+ papers
GHK-Cu Dosing Protocols for Skin Tightening Protocol design for GHK-Cu is relatively straightforward compared to some other peptides
I administer B12 injections subcutaneously, which means right under the skin and not into the muscle
Some users notice that their skin bounces back more readily, an indication of improved elastin function
US$ 27.18
US$ 21.83
US$ 23.05
US$ 21.39
